pregnancy in Heart disease

Slides:



Advertisements
Similar presentations
HEART DISEASE IN PREGNANCY A.MALIBARY, M.D. Associate Professor
Advertisements

PHYSIOLOGICAL CHANGES IN PREGNANCY AND CONGENITAL HEART DISEASE COMPLICATING PREGNANCY.
Heart Failure in Pregnancy
When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.
Cardioanaesthesia. Coronary artery disease O 2 delivery Coronary blood flow = directly related to coronary perfusion pressure (CPP) CPP = aortic diastolic.
CVS Changes During Pregnancy PARAMETERDIRECTIONTIME COURSE Heart rate ↑ 1 st and 2 nd trimester (TM) Blood pressure ↓ Fall in TM 1 and 2, returns to baseline.
DR. HANA OMER CONGENITAL HEART DEFECTS. The major development of the fetal heart occurs between the fourth and seventh weeks of gestation, and most congenital.
Cardiac Disease in Pregnancy. Physiological Changes in the Cardiovascular System During Pregnancy A thorough knowledge –essential In order to understand.
Golnaz Houshmand.MD Cardiologist. Why we concern !
Valvular Heart Disease. Normal heart valves function to maintain the direction of blood flow through the atria and ventricles to the rest of the body.
Scenario:  Hx.:  A 30-year-old multigravida at the 20 weeks’ gestation.  Has a mild SOB with activity.  She has no symptoms at rest.  Had a childhood.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child with a Cardiovascular Disorder.
CONGENITAL DISEASES Dr. Meg-angela Christi Amores.
Pregnancy Management Guidelines in Women with Cardiac Diseases
PREGNANCY AND HEART FAILURE PROF.DR. MUHAMMAD AKBAR CHAUDHARY M.R.C.P. (U.K.) F.R.C.P. (E) F.R.C.P. (LONDON) F.A.C.C Designed At A.V. Dept. F.J.M.C. By.
Outline The critical physiological changes of pregnancy. The critical physiological changes of pregnancy. Predictors of cardiac events during pregnancy.
RJS Valvular heart disease Richard Schilling St Mary’s Hospital London.
Valvular Heart DISEASE
Inflammatory and Structural Heart Disorders Valvular Heart Disease
Max Brinsmead MB BS PhD May  In the UK this has increased over time  Deaths in 1982 – per million births  in 2003 – per million.
Infective edocarditis. Definition  an infection of the endocardium or vascular endothelium  it may occur as fulminating or acute infection  more commonly.
Recommandations de la Société Européenne de Cardiologie sur les Cardiopathies et la Grossesse Bernard Iung, Hôpital Bichat,
CARDIAC DISEASES IN PREGNANCY DR. RAZAQ MASHA,FRCOG Assistant Professor & Consultant Department of Obstetrics & Gynaecology.
Cardiac Disease in Pregnancy
Heart disease with pregnancy Prof Uma Singh. Incidence of heart disease Varies between 0.1 – 4.0 %, average 1% Mortality due to heart disease has decreased.
PHYSIOLOGICAL CHANGES IN PREGNANCY AND CONGENITAL HEART DISEASE COMPLICATING PREGNANCY.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child With a Cardiovascular Disorder Maternity and.
CARDIAC DISEASE IN PREGNANCY. Physiologic Changes of Pregnancy Blood volume and cardiac output rise in pregnancy to a peak that is 150% of normal by 24.
Congenital Heart Disease in Children Dr. Sara Mitchell January
CYANOTIC CONGENITAL HEART DISEASE
Medical disorders associated with pregnancy. Care for women with pre-existing medical disorders (PEMD) should ideally take place before conception in.
MITRAL VALVE DISEASES. MITRAL VALVE DISEASES 1. Mitral valve stenosis. 2. Mitral valve regurge. 3. Mitral valve prolapse.
Medical Disease in Pregnancy Cardiovascular Disease Cullen Archer, MD Department of Obstetrics and Gynecology.
CARDIAC DISEASE IN PREGNANCY
HEART DISEASE IN PREGNANCY. The incidence of cardiac lesion is less than 1% among hospital deliveries. The commonest cardiac lesion is of rheumatic origin.
Adult Medical-Surgical Nursing
Cardiovascular disease in pregnancy Cardiovascular disease in pregnancy Dr.Z Allameh MD.
Interventions for Clients with Cardiac Problems.
Management of Heart Disease in Pregnancy.  It is estimated that 1% to 3% of women either have cardiac disease entering pregnancy or are diagnosed with.
Heart Disease In Pregnancy
CONGENITAL HEART DEFECTS DR. HANA OMER. CONGENITAL HEART DEFECTS D. HANA OMER.
Cardiac History & Examination
Heart disease & pregnancy Dr Movahedi Clinical indicators of Hear disease & pregnancy.
Pathophysiology BMS 243 Rheumatic Heart Disease
Adult with operated congenital heart disease: what should we check for? January 15 th, h-17h30.
Cardiac diseases in pregnancy. These women should be fully assessed before pregnancy and the maternal and fetal risks carefully explained. Cardiologist.
HEART DISEASE IN PREGNANCY. Mortality associated with specific cardiac lesions 1. Low risk of maternal mortality (less than 1%). (a) Septal defects. (b)
Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.
Cardiovascular Disease In Pregnancy It is a relatively common in women of child bearing age, complicate about 1% of pregnancies Maternal mortality related.
Akram Sardari.MD Fellowship Of Echocardiography Imam Khomeini Hospital VALVULAR DISEASE IN PREGNANCY.
Congenital heart disease
بنام خدا.
Au nom de Dieu le Tre`s Mise´ricordieux, Le Tout Mise´ricordieux
Cardiothoracic Surgery
Heart and Circulatory Failure
The cardiovascular system
In the name of God.
Heart disease with pregnancy
Pathophysiology BMS 243 Rheumatic Heart Disease
Homograft Replacement of the aortic valve:Ten-year results
Infective Endocarditis
Heart disease in pregnancy
Heart Disease in Pregnancy
HEMODYNAMIC CHANGES IN PREGNANCY AND CHD- COMPLICATING PREGNANCY
CYANOTIC CONGENITAL HEART DISEASE
Heart disease with pregnancy
MEDICAL ILLNESS COMPLICATING PREGNANCY
Congenital/Mitral Valve Prolapse
Pathological physiology of cardiovascular system 3
Endocarditis is an inflammation of the endocardium, the membrane lining the chambers of the heart and covering the cusps of the heart valves. Infective.
Presentation transcript:

pregnancy in Heart disease د.ايناس الخياط

Physiological effects of pregnancy on CVS :   - By 6 – 8 peripheral vasodilitation occur → » ↓ systemic vascular resistance ↑ Cardiac output(CO.) by 20 % . - ↑ CO. to about maximum of 40 % by 24 – 28 wks of gestation . so ↑ risk of H. F. in this period . - ↑ HR – 10 – 15 % . - ↑ CO up to 80%above pre-labour values in first few hrs after delivery . - CO. return to normal at 2 wks post delivery .

Issues in pre-pregnancy counselling of women with heart disease Risk of maternal death . Possible reduction of maternal life expectancy . Effects of pregnancy on cardiac disease . Mortality associated with high risk conditions . Risk of fetus developing congenital heart disease . Risk of preterm labour and FGR . Need for frequent hospital attendance and possible admission . Intensive maternal and fetal monitoring during labour . Other options – contraception , adoption , surrogacy . Timing of pregnancy .

Antenatal Management a joint obstetric / cardiac History Examination Investigations Follow up maternal &fetal well-being

The stages of heart failure-New work heart Association ( NYHA ) classification 1. Mild No limitation of physical activity . Ordinary physical activity does not precipitate fatigue , palpitations , dyspnoea , angina . 2. Mild Slight limitation of physical activity . Comfortable at rest , but ordinary physical activity results in fatigue, palpitation or dyspnoea. 3. Moderate Marked limitation of Physical activity . Comfortable at rest , but less than ordinary activity causes fatigue , palpitation or dyspnoea . 4. Severe Unable to carry out any physical activity without discomfort . Symptoms of cardiac insufficiency at rest . If any physical activity is undertaken , discomfort is increased .

Toronta risk markers for maternal cardiac events 1 Prior episode of heart failure , arrhythmia or stroke . 2 NYHA class > II or cyanosis . 3 Left heart obstruction . 4. Reduced left ventricular function ( EE < 40 per cent ) 0 predictors : risk of cardiac event is 5per cent ; I predictor : risk of cardiac event is 37 per cent ; > 1 predicators : risk of cardiac event is 75 per cent .

High-risk cardiac conditions Systemic ventricular dysfunction ( ejection fraction < 30 per cent , NYHA class III – IV ) . Pulmonary hypertension Cyanotic congenital heart disease . Aortic pathology ( dilated aortic root > 4 cm , Marfan syndrome ) . Ischaemic heart disease . Left heart obstructive lesions ( aortic , mitral stenosis ) Prosthetic heart valves ( metal ) . Previous peripartum cardiomyopathy .

Fetal risks of maternal cardiac disease Recurrence ( congenital heart disease ) . Maternal cyanosis ( fetal hypoxia ) . Iatrogenic prematurity . FGR . Effects of maternal drugs ( teratogenesis , growth restriction , fetal loss ) .

Maternal risks: -Endocarditis. -Arrythmias. - Paraxysmal embolic events. -Heart failure &pulmonary hypertention. - Death .

Risk factors for the development of heart failure Respiratory or urinary infections . Anaemia . Obesity . Corticosteroids . Tocolytics . Multiple gestation . Hypertension . Arrhymais . Pain-related stress . Fluid overload TREAT HEART FAILUR AS IN NON PREGNANT ONE

Management of labour and delivery Management of labour in women with heart disease Avoid induction of labour of possiblr . Use prophylactic antibiotic . Ensure fluid balance . Avoid the supine position . Discuss regional / epidural anaesthesia / analgesia with senior anaesthetist . Keep the second stage short . Use syntocinon judiciously .

Specific conditions Ischaemic heart disease Mitral and aortic stenosis Marfan syndrome Pulmonary hypertension : Peripartum cardiomyopathy ( CMP Coarctation of Aorta Prosthetic heart valves

Strategies of anticoagulant regimen in pregnancy:   (1.) Continue warfairn during pregnancy. ( or ) (2.) Replace warfarin with high dose heparin from 6th – 12th wks of gestation & 10 days before the delivery (3.) use high dose unfractionated or low molecular weight heparin throughout pregnancy.

Which option is chosen will depend on several factors: 1. Type of mechanical valve : the risk of thrombosis is less with the newer bi-leaflet valves than first & 2nd generation ball and cage valves . 2. The position of the value replacement : Mitral position > risk Aortic position 3. number of mechanical valves : Two valves give a high risk of thrombosis . 4. The dose of warfarin required to maintain a therapeutic INR . 5. Any previous history of embolic events .

Stratification of cardiac conditions according to risk of bacterial endocarditis :  - High-risk : Prosthetic valves , previous bacterial endocarditis , complex cyanotic congenital heart disease ( fallot's , transposition of great arteries ,surgical systemic / pulmonary shunt ) . acquired valvular disease .   Moderate risk : Hypertrophic cardiomyopathy . Mitral value prolapse with mitral regurge .  

Stratification of cardiac conditions according to risk of bacterial endocarditis : Negligible risk : Secundum ASD . Repaired ASD , VSD , PDA . mitral prolapse with or without regurgitation . Physiological Heart murmurs . Pacemakers .   For high & moderate risk : Endocarditis prophylaxis is recommended .